Pharmadrug Inc. (PHRX.CN)
CAD 0.01
(-33.33%)
CAD 0.01
(-33.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.33 Million CAD | -44.8% |
| 2022 | 2.41 Million CAD | -53.71% |
| 2021 | 5.22 Million CAD | 29.93% |
| 2020 | 4.02 Million CAD | -24.8% |
| 2019 | 5.34 Million CAD | 462.52% |
| 2018 | 950.52 Thousand CAD | 732.68% |
| 2017 | 114.15 Thousand CAD | -49.59% |
| 2016 | 226.42 Thousand CAD | -68.4% |
| 2015 | 716.63 Thousand CAD | -53.93% |
| 2014 | 1.55 Million CAD | 575.86% |
| 2013 | 230.13 Thousand CAD | 13.56% |
| 2012 | 202.65 Thousand CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 436.89 Thousand CAD | -72.87% |
| 2024 Q2 | 49.86 Thousand CAD | -88.06% |
| 2023 Q4 | 1.61 Million CAD | 688.82% |
| 2023 Q1 | 214.14 Thousand CAD | -4.83% |
| 2023 Q2 | 283.47 Thousand CAD | 32.38% |
| 2023 Q3 | 204.13 Thousand CAD | -27.99% |
| 2023 FY | 2.31 Million CAD | -4.4% |
| 2022 Q3 | 555.88 Thousand CAD | 1.0% |
| 2022 Q4 | 225.01 Thousand CAD | -59.52% |
| 2022 FY | 2.41 Million CAD | -53.71% |
| 2022 Q1 | 1.59 Million CAD | 22.1% |
| 2022 Q2 | 550.35 Thousand CAD | -65.57% |
| 2021 Q4 | 1.3 Million CAD | -0.62% |
| 2021 FY | 5.22 Million CAD | 29.93% |
| 2021 Q2 | 1.19 Million CAD | -14.54% |
| 2021 Q3 | 1.31 Million CAD | 10.07% |
| 2021 Q1 | 1.4 Million CAD | 76.71% |
| 2020 Q4 | 792.58 Thousand CAD | -35.44% |
| 2020 Q3 | 1.22 Million CAD | -9.55% |
| 2020 Q2 | 1.35 Million CAD | 111.09% |
| 2020 Q1 | 643.04 Thousand CAD | -78.4% |
| 2020 FY | 4.02 Million CAD | -24.8% |
| 2019 Q3 | 435.81 Thousand CAD | -69.13% |
| 2019 FY | 5.34 Million CAD | 462.52% |
| 2019 Q4 | 2.97 Million CAD | 583.01% |
| 2019 Q2 | 1.41 Million CAD | 144.12% |
| 2019 Q1 | 578.27 Thousand CAD | 172.22% |
| 2018 Q4 | 212.42 Thousand CAD | -63.5% |
| 2018 FY | 950.52 Thousand CAD | 732.68% |
| 2018 Q3 | 581.99 Thousand CAD | 1758.03% |
| 2018 Q2 | 31.32 Thousand CAD | -61.18% |
| 2018 Q1 | 80.67 Thousand CAD | 139.96% |
| 2017 Q2 | 23.34 Thousand CAD | -10.11% |
| 2017 Q4 | 33.62 Thousand CAD | 224.56% |
| 2017 Q3 | 10.35 Thousand CAD | -55.62% |
| 2017 FY | 114.15 Thousand CAD | -49.59% |
| 2017 Q1 | 25.96 Thousand CAD | -51.99% |
| 2016 Q3 | 40.77 Thousand CAD | -13.54% |
| 2016 Q1 | 48.07 Thousand CAD | -29.2% |
| 2016 Q2 | 47.16 Thousand CAD | -1.89% |
| 2016 FY | 226.42 Thousand CAD | -68.4% |
| 2016 Q4 | 54.08 Thousand CAD | 32.65% |
| 2015 FY | 716.63 Thousand CAD | -53.93% |
| 2015 Q4 | 67.89 Thousand CAD | 3419.65% |
| 2015 Q3 | 1929.00 CAD | -98.63% |
| 2015 Q2 | 141.16 Thousand CAD | -35.77% |
| 2015 Q1 | 219.77 Thousand CAD | -37.87% |
| 2014 Q3 | 333.58 Thousand CAD | -6.4% |
| 2014 Q1 | 523.85 Thousand CAD | 43.63% |
| 2014 FY | 1.55 Million CAD | 575.86% |
| 2014 Q4 | 353.76 Thousand CAD | 6.05% |
| 2014 Q2 | 356.38 Thousand CAD | -31.97% |
| 2013 Q4 | 364.72 Thousand CAD | 233.4% |
| 2013 Q2 | 26.58 Thousand CAD | -56.73% |
| 2013 Q1 | 61.44 Thousand CAD | 87.88% |
| 2013 FY | 230.13 Thousand CAD | 13.56% |
| 2013 Q3 | 109.39 Thousand CAD | 311.46% |
| 2012 FY | 202.65 Thousand CAD | 0.0% |
| 2012 Q3 | 3531.00 CAD | -78.47% |
| 2012 Q2 | 16.39 Thousand CAD | -82.65% |
| 2012 Q1 | 94.54 Thousand CAD | 7.21% |
| 2012 Q4 | 32.7 Thousand CAD | 826.2% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | 88.18 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -718.439% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | 88.605% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -1485.056% |
| The BC Bud Corporation | 1.28 Million CAD | -4.055% |
| BioNxt Solutions Inc. | 6.73 Million CAD | 80.191% |
| CordovaCann Corp. | 3.86 Million CAD | 65.428% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | 68.831% |
| Captor Capital Corp. | 16.28 Million CAD | 91.801% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | -89.173% |
| 1CM Inc. | 7.3 Million CAD | 81.732% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -141.978% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 72.231% |
| IM Cannabis Corp. | 22.63 Million CAD | 94.103% |
| Lobe Sciences Ltd. | 4.13 Million CAD | 67.693% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -240.377% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -2125.022% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | 24.491% |
| Ovation Science Inc. | 54.1 Thousand CAD | -2367.677% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | -2.268% |
| RAMM Pharma Corp. | 7.48 Million CAD | 82.153% |
| RIV Capital Inc. | 21.1 Million CAD | 93.674% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | 59.369% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 96.464% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 94.574% |
| 1933 Industries Inc. | 5.12 Million CAD | 73.952% |
| Red Light Holland Corp. | 2.02 Million CAD | 33.926% |
| Top Strike Resources Corp. | 3.63 Million CAD | 63.241% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 532.853% |
| Adastra Holdings Ltd. | 9.36 Million CAD | 85.738% |